Open AccessQuality of Life in Autosomal Dominant Polycystic Kidney Disease Patients not yet on Dialysis
Author(s) -
Dana V. Rizk,
Claudine Jurkovitz,
Emir Veledar,
Susan P. Bagby,
Deborah A. Baumgarten,
Frederic F. Rahbari-Oskoui,
Theodore I. Steinman,
Arlene B. Chapman
Publication year - 2009
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02410508
Subject(s) - medicine , autosomal dominant polycystic kidney disease , population , quality of life (healthcare) , blood pressure , dialysis , polycystic kidney disease , kidney disease , physical therapy , pulse pressure , cohort , disease , nursing , environmental health
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited progressive disorder associated with significant pain and discomfort affecting quality of life. This study determined the impact of pain medication use and other clinical, biochemical and genetic characteristics on the physical and mental well being of predialysis ADPKD patients using the Short Form 36 (SF-36) questionnaire.